Back to results
US 2013/0295091 A1Published application
Combination therapy including tumor associated antigen binding antibodies
AssigneesUniversity of Zurich, Ct Atlantic Ltd.
InventorsChristoph Esslinger, Alexander Knuth, Martin Treder, Maries Van Den Broek, Elke Jaeger
Life of this patent
Estimating the term…
Abstract
The present invention relates to a combination therapy including tumor associated antigen binding antibodies.
Claims22
A pharmaceutical composition comprising at least one tumor associated antigen (TAA) binding antibody or binding fragment thereof and at least one anti-CD40 agonistic antibody or binding fragment thereof, wherein the at least one TAA binding antibody or binding fragment thereof binds to NY-ESO-1.
A kit of pharmaceutical compositions comprising:
- a) a first pharmaceutical composition comprising at least one tumor associated antigen (TAA) binding antibody or binding fragment thereof;
- and
- b) a second pharmaceutical composition comprising at least one anti-CD40 agonistic antibody or binding fragment thereof,
- wherein the at least one TAA binding antibody or binding fragment thereof binds to NY-ESO-1.
1 more element
(canceled)
Dependencies are inferred from the claim text.